(Q33654557)

English

A prospective randomized study on two dose fractionation regimens of high-dose-rate brachytherapy for carcinoma of the uterine cervix: comparison of efficacies and toxicities between two regimens

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A prospective randomized study on two dose fractionation regimens of high-dose-rate brachytherapy for carcinoma of the uterine cervix: comparison of efficacies and toxicities between two regimens (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

author name string

Taek Keun Nam

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sung Ja Ahn

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Korean Medical Science

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

87-94

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2004

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

21 June 2018

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

21 June 2018

The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

21 June 2018

Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

21 June 2018

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

21 June 2018

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

21 June 2018

High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

21 June 2018

Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

30 October 2018

Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

30 October 2018

Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

30 October 2018

A simple method of obtaining equivalent doses for use in HDR brachytherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

30 October 2018

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

30 October 2018

The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

30 October 2018

Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822271

30 October 2018

Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of severe late complications in fractionated, high dose-rate brachytherapy in gynecological applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results

1 reference

https://pubmed.ncbi.nlm.nih.gov/14966348

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3346/JKMS.2004.19.1.87

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33654557&oldid=1990948572"